These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4831212)

  • 21. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 22. Editorial: APhA-government interactions.
    Griffenhagen GB
    J Am Pharm Assoc; 1974 Oct; 14(10):547. PubMed ID: 4423066
    [No Abstract]   [Full Text] [Related]  

  • 23. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug cost review--1987.
    Mehl B
    Hosp Pharm; 1988 Mar; 23(3):282-3. PubMed ID: 10318046
    [No Abstract]   [Full Text] [Related]  

  • 25. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Policy implications of drug importation.
    Palumbo FB; Mullins CD; Slagle AF; Rizer J
    Clin Ther; 2007 Dec; 29(12):2758-67. PubMed ID: 18201594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
    Wash Memo Alan Guttmacher Inst; 1992 Oct; (15):2-4. PubMed ID: 12317790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discussing expensive anticancer drugs.
    Jefford M; Mileshkin L; Schofield P; Agalianos E; Thomson J; Zalcberg J
    J Clin Oncol; 2009 Jan; 27(3):476-7. PubMed ID: 19075252
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug utilization--a public health problem.
    Brodie DC
    Ann Pharmacother; 2006 Nov; 40(11):2029. PubMed ID: 17062822
    [No Abstract]   [Full Text] [Related]  

  • 30. Concerning the Case of United States v. American Pharmaceutical Association and Michigan state Pharmaceutical Association Civil No. G75-558, CA5, W.D. Michigan.
    Apple WS
    Am Pharm; 1983 Aug; NS23(8):54-6. PubMed ID: 6624641
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 32. Concerning the case of United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association Civil No. G75-558, CA5, W.D. Michigan.
    Schlegel JF
    Am Pharm; 1984 Aug; NS24(8):74-6. PubMed ID: 6486017
    [No Abstract]   [Full Text] [Related]  

  • 33. The 1990 prevention objectives for alcohol and drug misuse: progress report.
    Segal M; Palsgrove G; Sevy TD; Collins TE
    Public Health Rep; 1983; 98(5):426-35. PubMed ID: 6414028
    [No Abstract]   [Full Text] [Related]  

  • 34. Concerning the case of United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, civil no. G75-558 CA5, W.D. Michigan.
    Apple WS
    Am Pharm; 1981 Aug; NS21(8):55-7. PubMed ID: 7270424
    [No Abstract]   [Full Text] [Related]  

  • 35. Concerning the case of United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W.D. Michigan.
    Am Pharm; 1982 Aug; NS22(8):49-51. PubMed ID: 7124620
    [No Abstract]   [Full Text] [Related]  

  • 36. Medicines, medical care, manpower and mankind.
    Francke DE
    Am J Hosp Pharm; 1971 Jun; 28(6):410-21. PubMed ID: 5124723
    [No Abstract]   [Full Text] [Related]  

  • 37. The older adult and drug therapy: Part two. Thirteen drugs and what they cost.
    Geriatr Nurs; 1982; 3(1):48-9. PubMed ID: 6916681
    [No Abstract]   [Full Text] [Related]  

  • 38. Concerning the case of American Pharmaceutical Association and Michigan State Pharmaceutical Association.
    Miles WA
    Am Pharm; 1989 Aug; NS29(8):33-5. PubMed ID: 2782242
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug prices approach all-time high.
    Hosp Purch Manage; 1986 Feb; 11(2):19-20. PubMed ID: 10317690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.